Peer-reviewed journal articles (257)
  1. 99. Capouillez, A., Decaestecker, C., Filleul, O., Chevalier, D., Coppee, F., Leroy, X., Belayew, A., & Saussez, S. (2008). Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas. Virchows Archiv, 453(5), 491-499. doi:10.1007/s00428-008-0675-9
  2. 100. Rorive, S., Berton, A., D'Haene, N., Takacs, C. N., Debeir, O., Decaestecker, C., & Salmon, I. (2008). Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas. GLIA, 56(15), 1679-1690. doi:10.1002/glia.20719
  3. 101. Debeir, O., Megalizzi, V., Warzée, N., Kiss, R., & Decaestecker, C. (2008). Videomicroscopic extraction of specific information on cell proliferation and migration in vitro. Experimental cell research, 314(16), 2985-2998. doi:10.1016/j.yexcr.2008.06.010
  4. 102. Saussez, S., Decaestecker, C., Mahillon, V., Cludts, S., Capouillez, A., Chevalier, D., Vet, H. K., André, S., Toubeau, G., Leroy, X., & Gabius, H.-J. (2008). Galectin-3 upregulation during tumor progression in head and neck cancer. The Laryngoscope, 118(9), 1583-1590. doi:10.1097/MLG.0b013e31817b0718
  5. 103. Pozdzik, A., Salmon, I., Husson, C., Decaestecker, C., Rogier, E., Bourgeade, M.-F., Deschodt Lanckman, M., Vanherweghem, J.-L., & Nortier, J. (2008). Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrology, dialysis, transplantation, 23(8), 2480-2491. doi:10.1093/ndt/gfn140
  6. 104. Dumont, P., Berton, A., Nagy, N., Sandras, F., Tinton, S., Demetter, P., Mascart, F., Allaoui, A., Decaestecker, C., & Salmon, I. (2008). Expression of galectin-3 in the tumor immune response in colon cancer. Laboratory investigation, 88(8), 896-906. doi:10.1038/labinvest.2008.54
  7. 105. Maris, C., Rorive, S., Sandras, F., D'Haene, N., Sadeghi-Meibodi, N., Bièche, I., Vidaud, M., Decaestecker, C., & Salmon, I. (2008). Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas. Neuropathology and applied neurobiology, 34(3), 316-329. doi:10.1111/j.1365-2990.2007.00898.x
  8. 106. Le Mercier, M., Lefranc, F., Mijatovic, T., Debeir, O., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Kiss, R., & Mathieu, V. (2008). Evidence of galectin-1 involvement in glioma chemoresistance. Toxicology and applied pharmacology, 229(2), 172-183. doi:10.1016/j.taap.2008.01.009
  9. 107. Mijatovic, T., Mahieu, T., Bruyère, C., De Nève, N., Dewelle, J., Simon, G., Dehoux, M., van der Aar, E., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Van Quaquebeke, E., Darro, F., & Kiss, R. (2008). UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. Neoplasia (New York, N.Y.), 10(6), 573-586. doi:10.1593/neo.08290
  10. 108. Demetter, P., Nagy, N., Martin, B., Mathieu, A., Dumont, P., Decaestecker, C., & Salmon, I. (2008). The galectin family and digestive disease. Journal of pathology, 215(1), 1-12. doi:10.1002/path.2334
  11. 109. Le Mercier, M., Mathieu, V., Haibe-Kains, B., Bontempi, G., Mijatovic, T., Decaestecker, C., Kiss, R., & Lefranc, F. (2008). Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. Journal of neuropathology and experimental neurology, 67(5), 456-469. doi:10.1097/NEN.0b013e318170f892
  12. 110. Mijatovic, T., De Nève, N., Gailly, P., Mathieu, V., Haibe-Kains, B., Bontempi, G., Lapeira, J., Decaestecker, C., Facchini, V., & Kiss, R. (2008). Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity. Molecular cancer therapeutics, 7(5), 1285-1296. doi:10.1158/1535-7163.MCT-07-2241
  13. 111. Saussez, S., Decaestecker, C., Lorfevre, F., Chevalier, D., Mortuaire, G., Kaltner, H., André, S., Toubeau, G., Gabius, H.-J., & Leroy, X. (2008). Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology, 52(4), 483-493. doi:10.1111/j.1365-2559.2008.02973.x
  14. 112. Pozdzik, A., Salmon, I., Debelle, F., Decaestecker, C., Van den Branden, C., Verbeelen, D., Deschodt Lanckman, M., Vanherweghem, J.-L., & Nortier, J. (2008). Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney international, 73(5), 595-607. doi:10.1038/sj.ki.5002714
  15. 113. Lemy, A., Wissing, K. M., Rorive, S., Zlotta, A., Roumeguere, T., Muniz Martinez, M. C., Decaestecker, C., Salmon, I., Abramowicz, D., Vanherweghem, J.-L., & Nortier, J. (2008). Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. American journal of kidney diseases, 51(3), 471-477. doi:10.1053/j.ajkd.2007.11.015
  16. 114. Sadeghi-Meibodi, N., D'Haene, N., Decaestecker, C., Levivier, M., Metens, T., Maris, C., Wikler, D., Balériaux, D., Salmon, I., & Goldman, S. (2008). Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. American journal of neuroradiology, 29(3), 476-482. doi:10.3174/ajnr.A0851
  17. 115. D'Haene, N., Catteau, X., Maris, C., Martin, B., Salmon, I., & Decaestecker, C. (2008). Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas. British journal of haematology, 140(4), 402-410. doi:10.1111/j.1365-2141.2007.06929.x
  18. 116. Saussez, S., Lorfevre, F., Lequeux, T., Laurent, G., Chantrain, G., Vertongen, F., Toubeau, G., Decaestecker, C., & Kiss, R. (2008). The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy. Oral oncology, 44(1), 86-93. doi:10.1016/j.oraloncology.2006.12.014
  19. 117. Megalizzi, V., Mathieu, V., Mijatovic, T., Gailly, P., Debeir, O., De Nève, N., Van Damme, M., Bontempi, G., Haibe-Kains, B., Decaestecker, C., Kondo, Y., Kiss, R., & Lefranc, F. (2007). 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia (New York, N.Y.), 9(5), 358-369.
  20. 118. Saussez, S., Decaestecker, C., Lorfevre, F., Cucu, D.-R., Mortuaire, G., Chevalier, D., Wacreniez, A., Kaltner, H., André, S., Toubeau, G., Camby, I., Gabius, H.-J., & Kiss, R. (2007). High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas. International journal of oncology, 30(5), 1109-1117.
    21. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>